Study finds that tumor monocyte content forecasts the effectiveness of immunochemotherapy for esophageal cancer.

Published Date: 12 Jul 2023

According to a Ludwig Cancer Research study, patients with esophageal cancer who receive combination therapy tend to fare better when there are relatively high numbers of immune cells called monocytes in tumors.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot